Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS
for Post-Acute COVID-19 Syndrome
1 location in Nashville
Sponsor: Vanderbilt University Medical Center
Sex: All·Age: 18+
Code: NCT07189936·Phase 2·Recruiting·Listed Sep 2025
Cyndya Shibao
Clinical research site in Nashville, Tennessee
As of July 2026, 1 paid clinical trial is recruiting at Cyndya Shibao in Nashville, Tennessee. Active studies at this site cover conditions such as Post-Acute COVID-19 Syndrome, Postural Tachycardia Syndrome (POTS) and SARS CoV 2 Infection. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Cyndya Shibao (1)
More research sites in Nashville
- Vanderbilt University Medical Center (369 trials)
- SCRI Oncology Partners (127 trials)
- Vanderbilt University/Ingram Cancer Center (86 trials)
- Sarah Cannon Research Institute (62 trials)
- Vanderbilt University (55 trials)
- Tennessee Oncology (48 trials)
- Vanderbilt-Ingram Cancer Center (39 trials)
- The Children's Hospital at TriStar Centennial (28 trials)
- Monroe Carell Jr. Children's Hospital at Vanderbilt (13 trials)
- Tennessee Oncology, PLLC (13 trials)
Explore more
Paid clinical trials in Nashville, TN · Tennessee clinical trials